首页 > 市场调查报告书 > 医疗设备

导管

消融设备市场规模、份额和成长分析（按技术、应用、最终用户和地区划分）—产业预测，2026-2033年

市场调查报告书

商品编码

1895578

消融设备市场规模、份额和成长分析（按技术、应用、最终用户和地区划分）—产业预测，2026-2033年

Ablation Devices Market Size, Share, and Growth Analysis, By Technology (Radiofrequency Devices, Laser/Light Ablation), By Application (Cardiology, Oncology), By End-user, By Region-Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 192 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球消融设备市场规模将达到 104.2 亿美元，到 2025 年将达到 115.6 亿美元，到 2033 年将达到 264.4 亿美元，预测期（2026-2033 年）的复合年增长率为 10.9%。

全球消融设备市场正经历显着成长，这主要得益于癌症和心血管疾病等慢性疾病发生率的上升，以及对微创手术需求的不断增长。这些用途广泛的设备被应用于心臟病学、肿瘤学、妇科和泌尿系统等多个医疗领域，推动了市场规模的扩大。射频消融、微波消融、冷冻消融和雷射消融等消融技术的不断进步，提高了手术效率和患者疗效，与传统手术相比，患者恢復更快，併发症更少。此外，医疗基础设施的完善、医疗支出的增加以及患者对创新治疗方案认知度的提高，也推动了市场的发展。然而，设备和手术的高成本构成了挑战，尤其对于新兴市场的小规模医疗机构而言，这阻碍了消融技术的广泛应用。

消融设备市场按技术、应用、最终用户和地区进行细分。依技术划分，可分为电磁波疗法、雷射/光消融设备、超音波设备、冷冻消融设备和其他技术。依应用划分，可分为心臟病学、肿瘤学、眼科、妇科学、泌尿系统科学、整形外科和其他应用。依最终用户划分，可分为医院、门诊手术中心和其他最终用户。依地区划分，可分为北美、亚太、欧洲、拉丁美洲以及中东和非洲。

全球消融设备市场成长要素

癌症、心血管疾病和神经系统疾病等慢性病的日益普遍是推动全球消融设备市场成长的主要因素。随着患者和医疗机构越来越多地选择非侵入性和微创治疗方法，消融技术在心房颤动、肝肿瘤和脊椎疾病等疾病治疗的应用也日益增多。这一趋势在老年患者中尤其明显，他们面临更高的手术风险，而消融被视为更安全、更有效的解决方案。为了因应医疗环境的这些变化，对消融设备的需求持续成长。

限制全球消融设备市场的因素

全球消融设备市场面临的一大障碍是部署、维护和营运这些先进系统所带来的沉重经济负担。先进消融技术（例如机器人辅助和人工智慧整合平台）所需的初始投资往往高得令人望而却步，限制了小规模医疗机构（尤其是在中低收入地区）获得这些技术的机会。此外，手术过程中产生的相关费用，例如一次性耗材、麻醉和术后护理，也会进一步加重本已捉襟见肘的医疗预算。这种经济障碍有可能阻碍创新消融解决方案在各种医疗机构中的广泛应用。

全球消融设备市场趋势

全球消融设备市场正呈现出一股显着的趋势，即整合人工智慧（AI）技术以提高消融手术的精准度和效率。人工智慧技术正被应用于消融系统，实现即时影像分析、自动病灶检测和个人化治疗方案製定。这些先进工具使临床医生能够轻鬆区分癌变组织和正常组织，从而更快、更准确地做出术中决策。透过优化消融过程中的能量输出并预测手术结果，人工智慧不仅可以最大限度地减少併发症，还能提高长期成功率。这将革新患者照护，并巩固其在不断发展的消融治疗领域中的关键作用。

Medtronic（Ireland）
Boston Scientific Corporation（USA）
Abbott Laboratories（USA）
Johnson & Johnson（USA）
AngioDynamics, Inc.（USA）
AtriCure, Inc.（USA）
Olympus Corporation（Japan）
Smith & Nephew plc（UK）
Stryker Corporation（USA）
Avanos Medical, Inc.（USA）
Hologic, Inc.（USA）
Becton, Dickinson and Company（USA）
Koninklijke Philips NV（Netherlands）
Baylis Medical Company, Inc.（Canada）
Elekta AB（Sweden）
Haifu Medical Technology Co., Ltd.（China）
Apyx Medical（formerly Bovie Medical）（USA）
LeMaitre Vascular, Inc.（USA）
Alcon Laboratories, Inc.（USA）
Biotronik SE & Co. KG（Germany）

结论与建议

简介目录

Product Code: SQMIG35A2603

Global Ablation Devices Market size was valued at USD 10.42 Billion in 2024 and is poised to grow from USD 11.56 Billion in 2025 to USD 26.44 Billion by 2033, growing at a CAGR of 10.9% in the forecast period (2026-2033).

The global ablation devices market is experiencing significant growth driven by heightened demand for minimally invasive procedures along with the rising incidence of chronic conditions such as cancer and cardiovascular diseases. These versatile devices find applications in various medical fields including cardiology, oncology, gynecology, and urology, thereby enhancing market reach. Continuous advancements in ablation technologies like radiofrequency, microwave, cryoablation, and lasers are improving procedural efficiency and patient outcomes, leading to quicker recoveries and reduced complications compared to traditional surgeries. Moreover, enhancements in healthcare infrastructure, increased spending, and greater patient awareness of innovative treatment options are propelling market development. However, high costs of equipment and procedures remain a challenge, particularly for smaller healthcare facilities in emerging markets, limiting broader adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ablation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ablation Devices Market Segments Analysis

The ablation devices market is segmented into technology, application, end-user and region. Based on technology, the market is segmented into radiofrequency devices, laser/light ablation, ultrasound devices, cryoablation devices and other technologies. Based on application, the market is segmented into cardiology, oncology, ophthalmology, gynecology, urology,cosmetic surgeryand other applications. Based on end-user, the market is segmented into hospitals, ambulatory surgical centers and other end users. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Ablation Devices Market

The increasing prevalence of chronic illnesses, including cancer, cardiovascular diseases, and neurological disorders, significantly propels the growth of the global ablation devices market. As patients and healthcare providers lean towards non-invasive and minimally invasive treatment options, the use of ablation techniques to manage conditions such as atrial fibrillation, liver tumors, and spinal disorders is on the rise. This trend is particularly pronounced among older adults, who often face heightened surgical risks; thus, ablation emerges as a safer and more efficient solution. Consequently, the demand for ablation devices continues to expand in response to these evolving healthcare dynamics.

Restraints in the Global Ablation Devices Market

A significant obstacle within the global ablation devices market is the considerable financial burden linked to the acquisition, upkeep, and operation of these sophisticated systems. The initial capital required for advanced ablation technology, such as robotic-assisted or AI-integrated platforms, is often prohibitively high, limiting access for smaller healthcare facilities, particularly in low- and middle-income regions. Furthermore, associated costs incurred during procedures, such as disposable materials, anesthesia, and post-operative care, can place additional strain on already constrained healthcare budgets. This financial barrier may hinder the widespread adoption of innovative ablation solutions in various healthcare settings.

Market Trends of the Global Ablation Devices Market

The Global Ablation Devices market is witnessing a significant trend towards the integration of Artificial Intelligence (AI) to enhance precision and efficiency in ablation procedures. AI technologies are being incorporated into ablation systems, enabling real-time imaging analysis, automatic lesion detection, and personalized treatment planning. These advanced tools empower clinicians to make quicker and more accurate intraoperative decisions, distinguishing cancerous tissues from healthy ones seamlessly. By optimizing energy delivery during ablation and predicting procedural outcomes, AI not only minimizes complications but also boosts long-term success rates, ultimately transforming patient care and solidifying its pivotal role in the evolving landscape of ablation therapies.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis

Global Ablation Devices Market Size by Technology & CAGR (2026-2033)

Market Overview
Radiofrequency devices
Laser/light ablation
Ultrasound devices
Cryoablation devices
Other technologies

Global Ablation Devices Market Size by Application & CAGR (2026-2033)

Market Overview
Cardiology
Oncology
Ophthalmology
Gynecology
Urology
Cosmetic surgery
Other applications

Global Ablation Devices Market Size by End-user & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory surgical centers
Other end users

Global Ablation Devices Market Size & CAGR (2026-2033)

North America (Technology, Application, End-user)
- US
- Canada
Europe (Technology, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanos Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baylis Medical Company, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haifu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apyx Medical (formerly Bovie Medical) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LeMaitre Vascular, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alcon Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments